CN1844010A - 磷酸钙水泥 - Google Patents
磷酸钙水泥 Download PDFInfo
- Publication number
- CN1844010A CN1844010A CNA2006100737422A CN200610073742A CN1844010A CN 1844010 A CN1844010 A CN 1844010A CN A2006100737422 A CNA2006100737422 A CN A2006100737422A CN 200610073742 A CN200610073742 A CN 200610073742A CN 1844010 A CN1844010 A CN 1844010A
- Authority
- CN
- China
- Prior art keywords
- calcium phosphate
- phosphate
- calcium
- compositions
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000001506 calcium phosphate Substances 0.000 title claims abstract description 155
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title claims abstract description 145
- 229910000389 calcium phosphate Inorganic materials 0.000 title claims abstract description 139
- 235000011010 calcium phosphates Nutrition 0.000 title claims abstract description 139
- 239000004568 cement Substances 0.000 title claims abstract description 78
- 239000011777 magnesium Substances 0.000 claims abstract description 64
- 239000007788 liquid Substances 0.000 claims abstract description 56
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 50
- 239000011707 mineral Substances 0.000 claims abstract description 50
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229960001714 calcium phosphate Drugs 0.000 claims description 136
- 239000000203 mixture Substances 0.000 claims description 99
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 claims description 57
- 239000002639 bone cement Substances 0.000 claims description 53
- 235000010755 mineral Nutrition 0.000 claims description 49
- 239000004615 ingredient Substances 0.000 claims description 46
- 239000000243 solution Substances 0.000 claims description 45
- 238000006243 chemical reaction Methods 0.000 claims description 42
- 238000002360 preparation method Methods 0.000 claims description 39
- 239000003340 retarding agent Substances 0.000 claims description 39
- 239000011230 binding agent Substances 0.000 claims description 36
- 239000001488 sodium phosphate Substances 0.000 claims description 32
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 30
- 235000011008 sodium phosphates Nutrition 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 24
- -1 sodium phosphate compound Chemical class 0.000 claims description 24
- 239000001509 sodium citrate Substances 0.000 claims description 19
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 19
- 229940038773 trisodium citrate Drugs 0.000 claims description 17
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 16
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 13
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- 239000000395 magnesium oxide Substances 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 10
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 10
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 9
- PLZNPHDJGFDNRM-UHFFFAOYSA-M O.[Na+].[O-][PH2]=O Chemical compound O.[Na+].[O-][PH2]=O PLZNPHDJGFDNRM-UHFFFAOYSA-M 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 6
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical group OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 5
- 239000002953 phosphate buffered saline Substances 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 claims description 3
- KDQPSPMLNJTZAL-UHFFFAOYSA-L disodium hydrogenphosphate dihydrate Chemical compound O.O.[Na+].[Na+].OP([O-])([O-])=O KDQPSPMLNJTZAL-UHFFFAOYSA-L 0.000 claims description 3
- PYLIXCKOHOHGKQ-UHFFFAOYSA-L disodium;hydrogen phosphate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O PYLIXCKOHOHGKQ-UHFFFAOYSA-L 0.000 claims description 3
- 229940045641 monobasic sodium phosphate Drugs 0.000 claims description 3
- 235000019691 monocalcium phosphate Nutrition 0.000 claims description 3
- 229910000150 monocalcium phosphate Inorganic materials 0.000 claims description 3
- 230000000278 osteoconductive effect Effects 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 claims description 3
- 150000003839 salts Chemical group 0.000 claims description 3
- 235000019983 sodium metaphosphate Nutrition 0.000 claims description 3
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 3
- 239000001226 triphosphate Substances 0.000 claims description 3
- ASTWEMOBIXQPPV-UHFFFAOYSA-K trisodium;phosphate;dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O ASTWEMOBIXQPPV-UHFFFAOYSA-K 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 claims description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 2
- GPSAAQWVJOVCBK-UHFFFAOYSA-N [K].[K].[K].OC(=O)CC(O)(C(O)=O)CC(O)=O Chemical compound [K].[K].[K].OC(=O)CC(O)(C(O)=O)CC(O)=O GPSAAQWVJOVCBK-UHFFFAOYSA-N 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000003607 modifier Substances 0.000 claims description 2
- 230000002138 osteoinductive effect Effects 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 239000012763 reinforcing filler Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims description 2
- 235000019801 trisodium phosphate Nutrition 0.000 claims description 2
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000012716 precipitator Substances 0.000 claims 2
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 claims 1
- 235000019738 Limestone Nutrition 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 150000004683 dihydrates Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 239000006028 limestone Substances 0.000 claims 1
- 229910001392 phosphorus oxide Inorganic materials 0.000 claims 1
- VSAISIQCTGDGPU-UHFFFAOYSA-N tetraphosphorus hexaoxide Chemical compound O1P(O2)OP3OP1OP2O3 VSAISIQCTGDGPU-UHFFFAOYSA-N 0.000 claims 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 abstract description 7
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 abstract description 7
- 229910000390 dicalcium phosphate Inorganic materials 0.000 abstract description 7
- 229940038472 dicalcium phosphate Drugs 0.000 abstract description 7
- 239000000523 sample Substances 0.000 description 36
- 238000012360 testing method Methods 0.000 description 36
- 239000000843 powder Substances 0.000 description 35
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 28
- 238000000227 grinding Methods 0.000 description 24
- 239000012065 filter cake Substances 0.000 description 20
- 238000002156 mixing Methods 0.000 description 19
- 238000001035 drying Methods 0.000 description 18
- 230000035515 penetration Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 229910000019 calcium carbonate Inorganic materials 0.000 description 14
- 235000019263 trisodium citrate Nutrition 0.000 description 14
- 238000000498 ball milling Methods 0.000 description 13
- 239000002002 slurry Substances 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- 235000011007 phosphoric acid Nutrition 0.000 description 11
- 238000001556 precipitation Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000002562 thickening agent Substances 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 8
- 229910001220 stainless steel Inorganic materials 0.000 description 8
- 239000010935 stainless steel Substances 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000005245 sintering Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 6
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 238000000634 powder X-ray diffraction Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000002572 peristaltic effect Effects 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 238000002441 X-ray diffraction Methods 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 235000012204 lemonade/lime carbonate Nutrition 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000003801 milling Methods 0.000 description 4
- 239000011812 mixed powder Substances 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003892 spreading Methods 0.000 description 4
- 230000007480 spreading Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 210000003464 cuspid Anatomy 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 238000004154 testing of material Methods 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000007704 wet chemistry method Methods 0.000 description 2
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000019957 Mimix Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 208000014735 Tooth injury Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium phosphate dihydrate Substances O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000009837 dry grinding Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000012120 mounting media Substances 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229910052585 phosphate mineral Inorganic materials 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- FDFYYWMHPJTGEO-UHFFFAOYSA-K tetracalcium;phosphate Chemical class [Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O FDFYYWMHPJTGEO-UHFFFAOYSA-K 0.000 description 1
- 239000011031 topaz Substances 0.000 description 1
- 229910052853 topaz Inorganic materials 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/34—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
- C04B28/344—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders the phosphate binder being present in the starting composition solely as one or more phosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/34—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Structural Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
步骤 | 温度(℃) | 时间(分钟) | 真空(毫乇) |
*R | -15 | 1 | 100 |
**H | -15 | 120 | 100 |
R | -5 | 120 | 200 |
H | -5 | 240 | 200 |
R | 0 | 120 | 1000 |
H | 0 | 600 | 1000 |
R | 10 | 60 | 1000 |
H | 10 | 30 | 1000 |
R | 20 | 60 | 1000 |
H | 20 | 30 | 1000 |
步骤 | 温度(℃) | 时间(分钟) | 真空(毫乇) |
*R | -5 | 1 | 100 |
**H | -5 | 480 | 100 |
R | 0 | 120 | 1000 |
H | 0 | 600 | 1000 |
R | 10 | 60 | 1000 |
H | 10 | 90 | 1000 |
R | 25 | 60 | 1000 |
H | 25 | 90 | 1000 |
步骤 | 温度(℃) | 时间(分钟) | 真空(毫乇) |
*R | -5 | 1 | 200 |
**H | -5 | 60 | 200 |
R | 0 | 60 | 1000 |
H | 0 | 120 | 1000 |
R | 10 | 60 | 1000 |
H | 10 | 30 | 1000 |
R | 20 | 60 | 1000 |
H | 20 | 60 | 1000 |
R | 30 | 60 | 1000 |
H | 30 | 300 | 1000 |
步骤 | 温度(℃) | 时间(分钟) | 真空(毫乇) |
*R | -15 | 1 | 100 |
**H | -15 | 120 | 100 |
R | -5 | 120 | 200 |
H | -5 | 240 | 200 |
R | 0 | 120 | 1000 |
H | 0 | 600 | 1000 |
R | 10 | 60 | 1000 |
H | 10 | 30 | 1000 |
R | 20 | 60 | 1000 |
H | 20 | 30 | 1000 |
步骤 | 温度(℃) | 时间(分钟) | 真空(毫乇) |
*R | -5 | 1 | 100 |
**H | -5 | 480 | 100 |
R | 0 | 120 | 1000 |
H | 0 | 600 | 1000 |
R | 10 | 60 | 1000 |
H | 10 | 90 | 1000 |
R | 25 | 60 | 1000 |
H | 25 | 90 | 1000 |
步骤 | 温度(℃) | 时间(分钟) | 真空(毫乇) |
*R | -5 | 1 | 200 |
**H | -5 | 60 | 200 |
R | 0 | 60 | 1000 |
H | 0 | 120 | 1000 |
R | 10 | 60 | 1000 |
H | 10 | 30 | 1000 |
R | 20 | 60 | 1000 |
H | 20 | 60 | 1000 |
R | 30 | 60 | 1000 |
H | 30 | 300 | 1000 |
原料 | 重量(克) | 百分数(%) |
CaCO3 | 1394.75±1 | 39.85 |
DCPA | 2105.25±1 | 60.15 |
水 | 3500.00±10 | 100 |
参数 | 设定 |
速度(rpm) | 44±4 |
时间(分钟) | 20 |
Buckner烧瓶容量(%) | 80 |
步骤 | 温度(℃) | 时间(分钟) | 升温速率(℃/分钟) |
升温 | 800 | 100 | 8 |
保温 | 800 | ≥120 | n/a |
升温 | 1550 | 94 | 8 |
保温 | 1550 | 720 | n/a |
冷却 | 800 | ≤10 | 75 |
冷却 | 20 | 15 | 52 |
参数 | 设定 |
筛 | 0.024英寸 |
叶轮速度 | 5000rpm |
参数 | 设定 |
速度(rpm) | 87+/-5 |
时间(分钟) | 360+/-15 |
加入的介质重量(克) | 3000+/-25 |
TTCP重量(克) | 600+/-25 |
化学名称 | 化学式 | Mw | 质量/升 | 摩尔浓度 |
无水磷酸氢二钠 | HNa2O4P | 141.96克 | 22.8克/升 | 0.1606M |
一水合磷酸二氢钠 | H2NaO4P·H2O | 137.99克 | 45.5克/升 | 0.3297M |
柠檬酸三钠 | C6H5Na3O7·2H2O | 294.10克 | 147.1克/升 | 0.500M |
样品编号 | 结果 |
1 | 3414psi @ 5分钟7227psi @ 10分钟 |
2 | 3723psi @ 5分钟6843psi @ 10分钟 |
3 | 2441psi @ 5分钟7444psi @ 10分钟 |
4 | 2615psi @ 5分钟6606psi @ 10分钟 |
5 | 2193psi @ 5分钟6243psi @ 10分钟 |
6 | 2341psi @ 5分钟7153psi @ 10分钟 |
样品平均值 | 2788psi @ 5分钟6919psi @ 10分钟 |
样品编号 | 结果 |
1 | 1947psi @ 5分钟4668psi @ 10分钟 |
2 | 1675psi @ 5分钟3947psi @ 10分钟 |
3 | 1649psi @ 5分钟4567psi @ 10分钟 |
4 | 2371psi @ 5分钟3047psi @ 10分钟 |
5 | 2096psi @ 5分钟5872psi @ 10分钟 |
6 | 2903psi @ 5分钟5483psi @ 10分钟 |
样品平均值 | 2106psi @ 5分钟4930psi @ 10分钟 |
化学名称 | 化学式 | Mw(克) | %重量/粉末组分的总重量 |
含40ppm镁的稳定的DCPD | CaHPO4·2H2O | 172.05 | 28.6 |
磷酸四钙 | Ca4O(PO4)2 | 366.26 | 61 |
柠檬酸三钠 | Na3C6H5O7·2H2O | 394.11 | 10.4 |
总量 | 100 |
化学名称 | 化学式 | Mw(克) | %重量/总重量(重量(克)) |
无水磷酸氢二钠 | Na2HPO4 | 141.96克 | 2.5 |
一水合磷酸二氢钠 | NaH2O4P·H2O | 137.99克 | 7.1 |
聚乙烯吡咯烷酮 | [-C6H9NO-]n | (111.1)n | 7.5 |
水 | H2O | 18 | 82.9 |
化学名称 | 化学式 | Mw(克) | %重量/总重量(重量(克)) |
无水磷酸氢二钠 | Na2HPO4 | 141.96克 | 2.7 |
一水合磷酸二氢钠 | NaH2O4P·H2O | 137.99克 | 7.7 |
羧甲基纤维素钠 | [-Na2C16H22O14-]n | (484.14)n | 2.2 |
水 | H2O | 18 | 87.4 |
真实时间 | 40℃时加速老化时间 | 50℃时加速老化时间 |
1.5个月 | ~13天 | ~6.5天 |
3个月 | ~26天 | ~13天 |
6个月 | 53天 | 26天 |
1年 | 105天 | 52天 |
2年 | 210天 | 105天 |
样品编号 | 结果 |
1 | 4416psi(30.45MPa)@ 10分钟 |
2 | 4587psi(31.63MPa)@ 10分钟 |
3 | 4559psi(31.44MPa)@ 10分钟 |
4 | 4649psi(32.06MPa)@ 10分钟 |
5 | 4155psi(28.65MPa)@ 10分钟 |
6 | 4549psi(31.37MPa)@ 10分钟 |
样品平均值 | 4486psi(30.93MPa)@ 10分钟 |
使用者 | 混合时间 | 转移时间结束 |
使用者1 | 35秒 | 1分24秒 |
使用者2 | 54秒 | 1分53秒 |
使用者3 | 53秒 | 2分5秒 |
使用者4 | 42秒 | 1分55秒 |
使用者5 | 45秒 | 1分52秒 |
测试样品 | 在3分钟30秒时注射力(N) |
1 | 73.1 |
2 | 73.3 |
3 | 77.3 |
4 | 111.6 |
5 | 67.2 |
平均 | 80.5 |
测试样品 | 拔出强度(N) |
1 | 156.2 |
2 | 193.4 |
3 | 530 |
4 | 554 |
5 | 500 |
平均 | 386.72 |
测试样品 | HA转化率%(2周) |
1 | 61.3 |
2 | 76.7 |
3 | 62.7 |
平均 | 66.9 |
测试样品 | 体积变化% |
1 | 0.63 |
2 | 0.94 |
3 | 0.54 |
平均 | 0.70 |
Claims (55)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/102,254 | 2005-04-08 | ||
US11/102,254 US7416602B2 (en) | 2005-04-08 | 2005-04-08 | Calcium phosphate cement |
US11/312,094 | 2005-12-20 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100927981A Division CN101264338B (zh) | 2005-04-08 | 2006-04-07 | 磷酸钙水泥 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1844010A true CN1844010A (zh) | 2006-10-11 |
CN100460021C CN100460021C (zh) | 2009-02-11 |
Family
ID=37062980
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100927981A Expired - Fee Related CN101264338B (zh) | 2005-04-08 | 2006-04-07 | 磷酸钙水泥 |
CNB2006100737422A Expired - Fee Related CN100460021C (zh) | 2005-04-08 | 2006-04-07 | 磷酸钙水泥 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100927981A Expired - Fee Related CN101264338B (zh) | 2005-04-08 | 2006-04-07 | 磷酸钙水泥 |
Country Status (2)
Country | Link |
---|---|
US (1) | US7416602B2 (zh) |
CN (2) | CN101264338B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127547A (zh) * | 2011-11-28 | 2013-06-05 | 成功大学 | 强化不崩解性的钙基骨水泥制剂 |
CN107343965A (zh) * | 2016-05-06 | 2017-11-14 | 中国科学院化学研究所 | 一种骨粘合剂及其制备方法 |
CN107428615A (zh) * | 2014-12-23 | 2017-12-01 | 圣戈班韦伯公司 | 包含基于磷酸盐化合物的水泥的酸/碱性粘结剂 |
CN107670103A (zh) * | 2017-09-15 | 2018-02-09 | 天津大学 | 聚乙烯吡络烷酮改性的骨水泥及制备方法 |
CN107670102A (zh) * | 2017-11-19 | 2018-02-09 | 赵亮 | 一种募集内源性细胞的骨生物复合材料和制备方法及应用 |
CN108635624A (zh) * | 2018-04-25 | 2018-10-12 | 武汉理工大学 | 一种抗溃散型可注射的磷酸镁基骨水泥 |
CN108671266A (zh) * | 2018-05-29 | 2018-10-19 | 璧典寒 | 一种人工骨修复材料及其制备方法和应用 |
CN108949893A (zh) * | 2017-08-04 | 2018-12-07 | 璧典寒 | 一种骨生物功能分析细胞培养板 |
US10182973B2 (en) | 2010-11-10 | 2019-01-22 | Stryker European Holdings I, Llc | Polymeric bone foam composition and method |
CN109749727A (zh) * | 2017-11-02 | 2019-05-14 | 中国石油化工股份有限公司 | 一种低温磷酸盐热固树脂胶凝体系及其制备方法 |
CN109749725A (zh) * | 2017-11-02 | 2019-05-14 | 中国石油化工股份有限公司 | 一种高温磷酸盐热固树脂胶凝体系及其制备方法 |
CN109749726A (zh) * | 2017-11-02 | 2019-05-14 | 中国石油化工股份有限公司 | 一种中温磷酸盐热固树脂胶凝体系及其制备方法 |
CN113750289A (zh) * | 2021-10-20 | 2021-12-07 | 香港大学深圳医院 | 基于磷酸钙的有机-无机复合生物活性材料及其制备方法 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8029183B2 (en) * | 2005-02-23 | 2011-10-04 | Biomet Manufacturing Corp. | Apparatus for mixing bone cement |
US7459018B2 (en) * | 2005-04-08 | 2008-12-02 | Howmedica Leibinger Inc. | Injectable calcium phosphate cement |
US20080178769A1 (en) * | 2007-01-30 | 2008-07-31 | Construction Research & Technology Gmbh | Kit and method for preparing a hardenable cementitious composition |
US8232327B2 (en) * | 2008-11-12 | 2012-07-31 | Howmedia Osteonics Corp | Tetra calcium phosphate based organophosphorus compositions and methods |
US8409538B2 (en) * | 2008-12-04 | 2013-04-02 | Skeletal Kinetics Llc | Tricalcium phosphate coarse particle compositions and methods for making the same |
US8673364B2 (en) * | 2009-09-28 | 2014-03-18 | Skeletal Kinetics, Llc | Rapid setting high strength calcium phosphate cements comprising cyclodextrins |
US8557038B2 (en) * | 2009-04-22 | 2013-10-15 | American Dental Association Foundation | Dual-phase calcium phosphate cement composition |
CA2784533C (en) | 2009-12-18 | 2016-02-09 | Howmedica Osteonics Corp. | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
EP2569342B1 (en) | 2010-05-11 | 2022-01-26 | Howmedica Osteonics Corp. | Organophosphorous, multivalent metal compounds,&polymer adhesive interpenetrating network compositions&methods |
US8765189B2 (en) | 2011-05-13 | 2014-07-01 | Howmedica Osteonic Corp. | Organophosphorous and multivalent metal compound compositions and methods |
US20140305344A1 (en) * | 2011-08-31 | 2014-10-16 | Metallic Organic Ltd | Magnesium phosphate biomaterials |
GB2503950A (en) * | 2012-07-14 | 2014-01-15 | Nobel Biocare Services Ag | An agent for promoting osseointegration of bone substitute materials |
GB2503949A (en) * | 2012-07-14 | 2014-01-15 | Nobel Biocare Services Ag | An agent for promoting osseointegration of implants |
GB2504679A (en) | 2012-08-03 | 2014-02-12 | Nobel Biocare Services Ag | Bone substitute structure and material |
CN103466987B (zh) * | 2013-09-16 | 2014-07-30 | 石家庄市长安育才建材有限公司 | 屏蔽混凝土中高含量泥土吸附聚羧酸减水剂的复合泥土吸附剂及其制备方法和使用方法 |
US9168114B2 (en) | 2013-10-17 | 2015-10-27 | B & D Dental Corp. | Method of making a dental prosthesis |
CN107417149A (zh) * | 2017-09-13 | 2017-12-01 | 贵州开磷磷石膏综合利用有限公司 | 一种磷酸钙硅镁水泥及其制备方法 |
WO2020152083A1 (en) * | 2019-01-24 | 2020-07-30 | Antwas Aps | Method for eradicating insect nests or animal underground channels |
CN111467564B (zh) * | 2020-03-25 | 2021-11-16 | 西安理工大学 | 一种自膨胀复合骨水泥及其制备方法 |
CN111888521B (zh) * | 2020-06-11 | 2021-12-17 | 上海禾麦医学科技有限公司 | 骨修复材料及其制备方法 |
CN111948153A (zh) * | 2020-07-16 | 2020-11-17 | 深圳市锦瑞生物科技有限公司 | 一种冻干试剂球、生化分析芯片及血清总钙测定方法 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2018410A (en) | 1933-12-11 | 1935-10-22 | Victor Chemical Works | Dentifrice preparation |
US4139599A (en) * | 1973-01-11 | 1979-02-13 | Colgate Palmolive Company | Process for preparing dicalcium phosphate dihydrate having a portion of the calcium displaced by divalent metal ion |
US4244931A (en) | 1979-05-29 | 1981-01-13 | Monsanto Company | Dicalcium phosphate dihydrate with improved stability |
US4312843A (en) | 1979-12-26 | 1982-01-26 | Stauffer Chemical Company | Dicalcium phosphate dihydrate having improved monofluorophosphate compatibility and process for the preparation thereof |
US4472365A (en) * | 1981-06-15 | 1984-09-18 | Stauffer Chemical Company | Dicalcium phosphate dihydrate having improved monofluorophosphate compatibility and process for the preparation thereof |
USRE33221E (en) | 1982-04-29 | 1990-05-22 | American Dental Association Health Foundation | Dental restorative cement pastes |
USRE33161E (en) | 1982-04-29 | 1990-02-06 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
US4612053A (en) | 1983-10-06 | 1986-09-16 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
US4828823A (en) * | 1986-04-07 | 1989-05-09 | Stauffer Chemical Company | Dicalcium phosphate dihydrate for fluoride dentifrice compositions |
US6002065A (en) | 1988-04-20 | 1999-12-14 | Norian Corporation | Kits for preparing calcium phosphate minerals |
US5047031A (en) | 1988-04-20 | 1991-09-10 | Norian Corporation | In situ calcium phosphate minerals method |
US4880610A (en) | 1988-04-20 | 1989-11-14 | Norian Corporation | In situ calcium phosphate minerals--method and composition |
US5178845A (en) | 1988-04-20 | 1993-01-12 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
US5962028A (en) | 1988-04-20 | 1999-10-05 | Norian Corporation | Carbonated hydroxyapatite compositions and uses |
US5129905A (en) | 1988-04-20 | 1992-07-14 | Norian Corporation | Methods for in situ prepared calcium phosphate minerals |
US6005162A (en) | 1988-04-20 | 1999-12-21 | Norian Corporation | Methods of repairing bone |
US4973168A (en) | 1989-01-13 | 1990-11-27 | Chan Kwan Ho | Vacuum mixing/bone cement cartridge and kit |
DE3915746A1 (de) * | 1989-05-13 | 1990-11-15 | Hoechst Ag | Verfahren und anlage zur herstellung von dicalciumphosphat |
US5149368A (en) | 1991-01-10 | 1992-09-22 | Liu Sung Tsuen | Resorbable bioactive calcium phosphate cement |
US5262166A (en) | 1991-04-17 | 1993-11-16 | Lty Medical Inc | Resorbable bioactive phosphate containing cements |
EP0520690B1 (en) | 1991-06-26 | 1995-11-02 | Nitta Gelatin Inc. | Calcium phosphate type hardening material for repairing living hard tissue |
US5782971B1 (en) | 1991-06-28 | 1999-09-21 | Norian Corp | Calcium phosphate cements comprising amorophous calcium phosphate |
US5605713A (en) | 1991-11-22 | 1997-02-25 | Boltong; Maria G. | Process for the preparation of calcium phosphate cements and its application as bio-materials |
WO1993016657A1 (en) * | 1992-02-28 | 1993-09-02 | Collagen Corporation | Injectable ceramic compositions and methods for their preparation and use |
DE4305276A1 (de) | 1993-02-20 | 1994-08-25 | Hoechst Ag | Verfahren zur Herstellung eines für den Einsatz in Zahnpasten geeigneten Dicalciumphosphat-Dihydrats |
US5522893A (en) | 1993-03-12 | 1996-06-04 | American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5525148A (en) | 1993-09-24 | 1996-06-11 | American Dental Association Health Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
US5496399A (en) | 1994-08-23 | 1996-03-05 | Norian Corporation | Storage stable calcium phosphate cements |
US5569442A (en) | 1994-11-04 | 1996-10-29 | Norian Corporation | Reactive tricalcium phosphate compositions and uses |
US6117456A (en) | 1995-05-19 | 2000-09-12 | Etex Corporation | Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
US6409972B1 (en) | 1995-06-06 | 2002-06-25 | Kwan-Ho Chan | Prepackaged liquid bone cement |
US6953594B2 (en) | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
ATE269720T1 (de) | 1996-10-16 | 2004-07-15 | Etex Corp | Verfahren zur herstellung von niedrigkristallinen calciumphosphat und verfahren zu dessen verwendung |
DE19816858A1 (de) | 1998-04-16 | 1999-10-21 | Merck Patent Gmbh | Tricalciumphosphathaltige Biozementpasten mit Kohäsionspromotoren |
US5968253A (en) | 1998-07-31 | 1999-10-19 | Norian Corporation | Calcium phosphate cements comprising antimicrobial agents |
WO2000007639A1 (en) | 1998-08-07 | 2000-02-17 | Tissue Engineering, Inc. | Bone precursor compositions |
US6642285B1 (en) | 1999-02-02 | 2003-11-04 | Robert Mathys Stiftung | Implant comprising calcium cement and hydrophobic liquid |
US6379453B1 (en) | 1999-07-14 | 2002-04-30 | Jiin-Huey Chern | Process for producing fast-setting, bioresorbable calcium phosphate cements |
WO2001041821A1 (en) | 1999-12-09 | 2001-06-14 | Biosyntech Canada Inc. | Mineral-polymer hybrid composition |
MXPA02004591A (es) | 1999-12-09 | 2004-09-10 | Stratec Medical Ag | Cemento hidraulico brushita estabilizado con una sal de magnesio. |
FR2805748B1 (fr) | 2000-03-01 | 2002-09-13 | Ceravic | Procede de preparation d'un materiau pateux phosphocalcique injectable en vue de former un biomateriau apatitique et application chirurgicale ou dentaire |
US6375935B1 (en) | 2000-04-28 | 2002-04-23 | Brent R. Constantz | Calcium phosphate cements prepared from silicate solutions |
US7294187B2 (en) | 2001-01-24 | 2007-11-13 | Ada Foundation | Rapid-hardening calcium phosphate cement compositions |
US6793725B2 (en) | 2001-01-24 | 2004-09-21 | Ada Foundation | Premixed calcium phosphate cement pastes |
CN1162187C (zh) * | 2001-02-22 | 2004-08-18 | 华东理工大学 | 无机骨粘合剂及其在人体硬组织修复中的应用 |
ES2545256T3 (es) * | 2001-11-14 | 2015-09-09 | Ecole polytechnique fédérale de Lausanne (EPFL) | Multicomponentes pastosos para cementos fosfocálcicos inyectables |
KR20050012291A (ko) | 2002-06-19 | 2005-01-31 | 닥터.에이치.씨. 로버트 마티즈 스티프텅 | 수술용 인산칼슘 기재 수경성 시멘트 |
CA2438742C (en) | 2002-08-27 | 2011-08-09 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | A new calcium phosphate cement composition and a method for the preparation thereof |
WO2005009481A2 (de) | 2003-07-18 | 2005-02-03 | Biomet Deutschland Gmbh | Tensidhaltiger knochenzement |
US7351280B2 (en) | 2004-02-10 | 2008-04-01 | New York University | Macroporous, resorbable and injectible calcium phosphate-based cements (MCPC) for bone repair, augmentation, regeneration, and osteoporosis treatment |
CN1292804C (zh) * | 2004-03-08 | 2007-01-03 | 西安交通大学 | 含锶纳米磷酸钙生物活性骨水泥的制备工艺 |
EP1740233A1 (en) | 2004-03-08 | 2007-01-10 | Dr.h.c. Robert Mathys Stiftung | Hydraulic cement based on calcium phosphate for surgical use |
CN1304063C (zh) * | 2004-10-22 | 2007-03-14 | 中国科学院上海硅酸盐研究所 | 一种原位自固化生物活性材料、制备及应用 |
-
2005
- 2005-04-08 US US11/102,254 patent/US7416602B2/en active Active
-
2006
- 2006-04-07 CN CN2008100927981A patent/CN101264338B/zh not_active Expired - Fee Related
- 2006-04-07 CN CNB2006100737422A patent/CN100460021C/zh not_active Expired - Fee Related
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11185475B2 (en) | 2010-11-10 | 2021-11-30 | Stryker European Operations Holdings Llc | Polymeric bone foam composition and method |
US10182973B2 (en) | 2010-11-10 | 2019-01-22 | Stryker European Holdings I, Llc | Polymeric bone foam composition and method |
CN103127547B (zh) * | 2011-11-28 | 2015-04-01 | 成功大学 | 强化不崩解性的钙基骨水泥制剂 |
CN103127547A (zh) * | 2011-11-28 | 2013-06-05 | 成功大学 | 强化不崩解性的钙基骨水泥制剂 |
CN107428615A (zh) * | 2014-12-23 | 2017-12-01 | 圣戈班韦伯公司 | 包含基于磷酸盐化合物的水泥的酸/碱性粘结剂 |
CN107343965A (zh) * | 2016-05-06 | 2017-11-14 | 中国科学院化学研究所 | 一种骨粘合剂及其制备方法 |
CN107343965B (zh) * | 2016-05-06 | 2020-04-24 | 中国科学院化学研究所 | 一种骨粘合剂及其制备方法 |
CN108949893A (zh) * | 2017-08-04 | 2018-12-07 | 璧典寒 | 一种骨生物功能分析细胞培养板 |
CN107670103A (zh) * | 2017-09-15 | 2018-02-09 | 天津大学 | 聚乙烯吡络烷酮改性的骨水泥及制备方法 |
CN109749727A (zh) * | 2017-11-02 | 2019-05-14 | 中国石油化工股份有限公司 | 一种低温磷酸盐热固树脂胶凝体系及其制备方法 |
CN109749725A (zh) * | 2017-11-02 | 2019-05-14 | 中国石油化工股份有限公司 | 一种高温磷酸盐热固树脂胶凝体系及其制备方法 |
CN109749726A (zh) * | 2017-11-02 | 2019-05-14 | 中国石油化工股份有限公司 | 一种中温磷酸盐热固树脂胶凝体系及其制备方法 |
CN107670102A (zh) * | 2017-11-19 | 2018-02-09 | 赵亮 | 一种募集内源性细胞的骨生物复合材料和制备方法及应用 |
CN108635624A (zh) * | 2018-04-25 | 2018-10-12 | 武汉理工大学 | 一种抗溃散型可注射的磷酸镁基骨水泥 |
CN108671266A (zh) * | 2018-05-29 | 2018-10-19 | 璧典寒 | 一种人工骨修复材料及其制备方法和应用 |
CN113750289A (zh) * | 2021-10-20 | 2021-12-07 | 香港大学深圳医院 | 基于磷酸钙的有机-无机复合生物活性材料及其制备方法 |
WO2023065474A1 (zh) * | 2021-10-20 | 2023-04-27 | 香港大学深圳医院 | 基于磷酸钙的有机-无机复合生物活性材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US7416602B2 (en) | 2008-08-26 |
US20060225620A1 (en) | 2006-10-12 |
CN101264338A (zh) | 2008-09-17 |
CN100460021C (zh) | 2009-02-11 |
CN101264338B (zh) | 2012-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1844010A (zh) | 磷酸钙水泥 | |
CN1213775C (zh) | 作为骨传导和生物可降解的骨代用材料的磷酸钙人造骨 | |
JP5801280B2 (ja) | リン酸カルシウム系セメント | |
CN101076344A (zh) | 多用途生物材料组合物 | |
CN1154490C (zh) | 塞内昔布组合物 | |
CN1443176A (zh) | 缬沙坦的盐 | |
Liang et al. | Integrating silicon/zinc dual elements with PLGA microspheres in calcium phosphate cement scaffolds synergistically enhances bone regeneration | |
CN1771208A (zh) | 制备用于口腔疾病治疗的粒状、生物活性或可再吸收的生物硅酸盐的方法和组合物 | |
CN1055864C (zh) | 制备造影介质的方法 | |
Lee et al. | Titanium-Zirconium Binary Alloy as Dental Implant Material: Analysis of the Influence of Compositional Change on Mechanical Properties and In Vitro Biologic Response. | |
CN1826145A (zh) | 改进的磷酸钙骨水泥 | |
CN1845724A (zh) | 含服药物的输送 | |
CN1906188A (zh) | 作为igf-1r抑制剂的苯基-[4-(3-苯基-1h-吡唑-4-基)-嘧啶-2-基]-胺衍生物 | |
CN1599606A (zh) | 包含雌激素激动剂/拮抗剂、雌激素与孕激素组合的药物组合物、试剂盒和方法 | |
CN1950053A (zh) | 超声固化牙齿填充材料 | |
CN1317970A (zh) | 用aP2抑制剂和组合剂治疗动脉粥样硬化的方法 | |
Decambron et al. | Effect of the bone morphogenetic protein-2 doses on the osteogenic potential of human multipotent stromal cells-containing tissue engineered constructs | |
CN1703207A (zh) | GSK-3β抑制剂在制备增加骨生成的药物中的应用 | |
CN1958082A (zh) | 一种用于骨修复的矿化多肽材料及其制备方法 | |
CN1307490A (zh) | 一种人造生物材料化合物 | |
CN1481385A (zh) | 制剂抗生素化合物的方法 | |
CN87102744A (zh) | 一种刺激软骨细胞和成骨细胞的组合物(骨胶原羟基磷灰石化合物),其制备方法以及含有该组合物的药品 | |
CN1852862A (zh) | 一种新型羟基磷灰石磷酸钙粒子,其制备方法及其用途 | |
CN1159313C (zh) | 地洛他定多元酸碱金属或碱土金属盐复合盐及其药用组合物 | |
CN1680240A (zh) | 含白藜芦醇和大豆异黄酮的组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: STRYKER CORP Free format text: FORMER NAME: HOWMEDICA LEIBINGER CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Michigan Patentee after: STRYKER Corp. Address before: Michigan Patentee before: Halma Diocletian Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: HOWMEDICA OSTEONICS CO., LTD. Free format text: FORMER OWNER: STRYKER CORP. Effective date: 20110127 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: MICHIGAN, USA TO: NEW JERSEY, USA |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110127 Address after: New jersey, USA Patentee after: Howmedica Osteonics Corp. Address before: Michigan Patentee before: STRYKER Corp. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090211 |
|
CF01 | Termination of patent right due to non-payment of annual fee |